Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2,388 health care providers

Emily S. Van Laar, Jayashri Mehta Desai, Aminah Jatoi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Purpose: Because as many as 30 % of cancer patients who receive chemotherapy of moderate or high emetogenic potential suffer from chemotherapy-induced nausea and vomiting (CINV), we undertook a multinational survey to identify health care providers’ perceived knowledge gaps, barriers, and educational interests relevant to CINV.

Methods: An Internet-based survey was developed and was electronically disseminated to members of Medscape, an international Internet-based continuing medical education provider.

Results: A total of 2,388 health care providers responded to the survey. Although breakthrough nausea and vomiting was the most common CINV-related issue they managed in the preceding year, managing delayed nausea was the most problematic in that time period. Thirty-two percent of health care providers delayed or discontinued a patient’s chemotherapy because of CINV. Cost of antiemetics, patients’ poor adherence to antiemetic regimens, and health care providers’ underestimation of risk for CINV were all barriers to effective management. Health care providers expressed a wide range of educational interests, including managing breakthrough CINV, keeping up with novel antiemetic agents, and learning about emerging approaches for CINV prevention/management.

Conclusions: This survey of health care providers uncovered key barriers and educational needs relevant to the management of CINV. The findings from this survey can be used to develop educational initiatives focused on improving the care of cancer patients at risk for or suffering from CINV.

Original languageEnglish (US)
Pages (from-to)151-157
Number of pages7
JournalSupportive Care in Cancer
Volume23
Issue number1
DOIs
StatePublished - Dec 10 2014

Fingerprint

Health Personnel
Nausea
Vomiting
Drug Therapy
Antiemetics
Internet
Surveys and Questionnaires
Continuing Medical Education
Patient Compliance
Neoplasms
Patient Care
Learning
Costs and Cost Analysis

Keywords

  • Cancer
  • Chemotherapy
  • CINV
  • Education
  • Survey

ASJC Scopus subject areas

  • Oncology

Cite this

Professional educational needs for chemotherapy-induced nausea and vomiting (CINV) : multinational survey results from 2,388 health care providers. / Van Laar, Emily S.; Desai, Jayashri Mehta; Jatoi, Aminah.

In: Supportive Care in Cancer, Vol. 23, No. 1, 10.12.2014, p. 151-157.

Research output: Contribution to journalArticle

@article{e2e8f52f6575455b84d015aeafc3ea53,
title = "Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2,388 health care providers",
abstract = "Purpose: Because as many as 30 {\%} of cancer patients who receive chemotherapy of moderate or high emetogenic potential suffer from chemotherapy-induced nausea and vomiting (CINV), we undertook a multinational survey to identify health care providers’ perceived knowledge gaps, barriers, and educational interests relevant to CINV.Methods: An Internet-based survey was developed and was electronically disseminated to members of Medscape, an international Internet-based continuing medical education provider.Results: A total of 2,388 health care providers responded to the survey. Although breakthrough nausea and vomiting was the most common CINV-related issue they managed in the preceding year, managing delayed nausea was the most problematic in that time period. Thirty-two percent of health care providers delayed or discontinued a patient’s chemotherapy because of CINV. Cost of antiemetics, patients’ poor adherence to antiemetic regimens, and health care providers’ underestimation of risk for CINV were all barriers to effective management. Health care providers expressed a wide range of educational interests, including managing breakthrough CINV, keeping up with novel antiemetic agents, and learning about emerging approaches for CINV prevention/management.Conclusions: This survey of health care providers uncovered key barriers and educational needs relevant to the management of CINV. The findings from this survey can be used to develop educational initiatives focused on improving the care of cancer patients at risk for or suffering from CINV.",
keywords = "Cancer, Chemotherapy, CINV, Education, Survey",
author = "{Van Laar}, {Emily S.} and Desai, {Jayashri Mehta} and Aminah Jatoi",
year = "2014",
month = "12",
day = "10",
doi = "10.1007/s00520-014-2325-x",
language = "English (US)",
volume = "23",
pages = "151--157",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - Professional educational needs for chemotherapy-induced nausea and vomiting (CINV)

T2 - multinational survey results from 2,388 health care providers

AU - Van Laar, Emily S.

AU - Desai, Jayashri Mehta

AU - Jatoi, Aminah

PY - 2014/12/10

Y1 - 2014/12/10

N2 - Purpose: Because as many as 30 % of cancer patients who receive chemotherapy of moderate or high emetogenic potential suffer from chemotherapy-induced nausea and vomiting (CINV), we undertook a multinational survey to identify health care providers’ perceived knowledge gaps, barriers, and educational interests relevant to CINV.Methods: An Internet-based survey was developed and was electronically disseminated to members of Medscape, an international Internet-based continuing medical education provider.Results: A total of 2,388 health care providers responded to the survey. Although breakthrough nausea and vomiting was the most common CINV-related issue they managed in the preceding year, managing delayed nausea was the most problematic in that time period. Thirty-two percent of health care providers delayed or discontinued a patient’s chemotherapy because of CINV. Cost of antiemetics, patients’ poor adherence to antiemetic regimens, and health care providers’ underestimation of risk for CINV were all barriers to effective management. Health care providers expressed a wide range of educational interests, including managing breakthrough CINV, keeping up with novel antiemetic agents, and learning about emerging approaches for CINV prevention/management.Conclusions: This survey of health care providers uncovered key barriers and educational needs relevant to the management of CINV. The findings from this survey can be used to develop educational initiatives focused on improving the care of cancer patients at risk for or suffering from CINV.

AB - Purpose: Because as many as 30 % of cancer patients who receive chemotherapy of moderate or high emetogenic potential suffer from chemotherapy-induced nausea and vomiting (CINV), we undertook a multinational survey to identify health care providers’ perceived knowledge gaps, barriers, and educational interests relevant to CINV.Methods: An Internet-based survey was developed and was electronically disseminated to members of Medscape, an international Internet-based continuing medical education provider.Results: A total of 2,388 health care providers responded to the survey. Although breakthrough nausea and vomiting was the most common CINV-related issue they managed in the preceding year, managing delayed nausea was the most problematic in that time period. Thirty-two percent of health care providers delayed or discontinued a patient’s chemotherapy because of CINV. Cost of antiemetics, patients’ poor adherence to antiemetic regimens, and health care providers’ underestimation of risk for CINV were all barriers to effective management. Health care providers expressed a wide range of educational interests, including managing breakthrough CINV, keeping up with novel antiemetic agents, and learning about emerging approaches for CINV prevention/management.Conclusions: This survey of health care providers uncovered key barriers and educational needs relevant to the management of CINV. The findings from this survey can be used to develop educational initiatives focused on improving the care of cancer patients at risk for or suffering from CINV.

KW - Cancer

KW - Chemotherapy

KW - CINV

KW - Education

KW - Survey

UR - http://www.scopus.com/inward/record.url?scp=84919383797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919383797&partnerID=8YFLogxK

U2 - 10.1007/s00520-014-2325-x

DO - 10.1007/s00520-014-2325-x

M3 - Article

C2 - 25015057

AN - SCOPUS:84919383797

VL - 23

SP - 151

EP - 157

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 1

ER -